Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors: It Is Now Time for Cardio-Immuno-Oncology

J Am Coll Cardiol. 2018 Apr 24;71(16):1765-1767. doi: 10.1016/j.jacc.2018.02.038. Epub 2018 Mar 19.

Authors

Carlo G Tocchetti¹, Maria Rosaria Galdiero², Gilda Varricchi²

Affiliations

¹ Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, Federico II University, Naples, Italy. Electronic address: carlogabriele.tocchetti@unina.it.
² Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, Federico II University, Naples, Italy.

PMID: 29567211
DOI: 10.1016/j.jacc.2018.02.038

No abstract available

Keywords: cancer; cardiotoxicity; immune checkpoints inhibitors; myocarditis.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiotoxicity
Humans
Immunologic Factors
Medical Oncology
Myocarditis*
Neoplasms*

Substances

Immunologic Factors